CN101012197A - 5-(4-氯-苯基)-n-羟基-1-(4-甲氧基-苯基)-n-甲基-1h-吡唑-3-丙酰胺的合成新方法及药物用途 - Google Patents
5-(4-氯-苯基)-n-羟基-1-(4-甲氧基-苯基)-n-甲基-1h-吡唑-3-丙酰胺的合成新方法及药物用途 Download PDFInfo
- Publication number
- CN101012197A CN101012197A CN 200710053988 CN200710053988A CN101012197A CN 101012197 A CN101012197 A CN 101012197A CN 200710053988 CN200710053988 CN 200710053988 CN 200710053988 A CN200710053988 A CN 200710053988A CN 101012197 A CN101012197 A CN 101012197A
- Authority
- CN
- China
- Prior art keywords
- tepoxalin
- compound
- phenyl
- formula
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | n | 注射冰醋酸后第一次扭体时间(分) | 1小时内扭体次数 | 抑制率% |
CMC | 5 | 5.6±0.6 | 95.2±21.1 | - |
块状替泊沙林0.45mg/kg | 5 | 12.5±0.7** | 23.8±7.8** | 75 |
块状替泊沙林0.9mg/kg | 5 | 12.4±2.5** | 25.7±10.1** | 73 |
粉末状替泊沙林0.45mg/kg | 5 | 11.5±0.7** | 24.8±7.8** | 67 |
粉末状替泊沙林0.9mg/kg | 5 | 11.4±2.5** | 26.7±10.1** | 65 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100539888A CN100560570C (zh) | 2007-02-13 | 2007-02-13 | 5-(4-氯-苯基)-n-羟基-1-(4-甲氧基-苯基)-n-甲基-1h-吡唑-3-丙酰胺的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100539888A CN100560570C (zh) | 2007-02-13 | 2007-02-13 | 5-(4-氯-苯基)-n-羟基-1-(4-甲氧基-苯基)-n-甲基-1h-吡唑-3-丙酰胺的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101012197A true CN101012197A (zh) | 2007-08-08 |
CN100560570C CN100560570C (zh) | 2009-11-18 |
Family
ID=38699939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2007100539888A Active CN100560570C (zh) | 2007-02-13 | 2007-02-13 | 5-(4-氯-苯基)-n-羟基-1-(4-甲氧基-苯基)-n-甲基-1h-吡唑-3-丙酰胺的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100560570C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109824687A (zh) * | 2019-03-26 | 2019-05-31 | 上海凌凯医药科技有限公司 | 呋喃木糖衍生物的新合成方法 |
CN114181088A (zh) * | 2021-12-21 | 2022-03-15 | 大连大学 | 一种离子液体[TEA][TfOH]2催化制备α-卤代苯乙酮类化合物的方法 |
-
2007
- 2007-02-13 CN CNB2007100539888A patent/CN100560570C/zh active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109824687A (zh) * | 2019-03-26 | 2019-05-31 | 上海凌凯医药科技有限公司 | 呋喃木糖衍生物的新合成方法 |
CN109824687B (zh) * | 2019-03-26 | 2022-03-22 | 上海凌凯医药科技有限公司 | 呋喃木糖衍生物的新合成方法 |
CN114181088A (zh) * | 2021-12-21 | 2022-03-15 | 大连大学 | 一种离子液体[TEA][TfOH]2催化制备α-卤代苯乙酮类化合物的方法 |
CN114181088B (zh) * | 2021-12-21 | 2024-05-17 | 大连大学 | 一种离子液体[TEA][TfOH]2催化制备α-卤代苯乙酮类化合物的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100560570C (zh) | 2009-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102395566B (zh) | 吡唑基丙烯腈类化合物及其应用 | |
Arjun et al. | Crystal structure, Hirshfeld surface analysis, DFT and molecular docking studies on benzohydrazide derivatives as potential inhibitors of prostate cancer | |
CN107365248A (zh) | 二氟甲氧基取代的二苯乙烷及反式二苯乙烯衍生物及其制备方法和应用 | |
CN106397445A (zh) | 含有色酮结构的吡唑类n‐对溴苯基马来酰亚胺衍生物及其制备方法与应用 | |
CN100560570C (zh) | 5-(4-氯-苯基)-n-羟基-1-(4-甲氧基-苯基)-n-甲基-1h-吡唑-3-丙酰胺的合成方法 | |
Kotali et al. | Synthesis of novel dehydroacetic acid N-aroylhydrazone-derived boron heterocycles | |
CN104327053A (zh) | 氘代克里唑蒂尼及其衍生物、制备方法及应用 | |
CN102603553B (zh) | 具有协同抗真菌作用的化合物及其在药学中的用途 | |
CN106083884B (zh) | 一种d-亮氨酸取代去甲斑蝥素衍生物及其制备方法与应用 | |
CN102718675A (zh) | 阿戈美拉汀甲磺酸复合物及其制备方法 | |
Ren et al. | Thermal properties and DNA-binding studies of a new kind of acyl hydrazone compounds containing imidazole ring | |
CN108341807B (zh) | 含苯并二噁烷骨架的哌嗪酰胺类化合物及其制备方法和应用 | |
WO2009133389A1 (en) | Methods of preparing substituted heterocycles | |
CN103119024A (zh) | 异喹啉衍生物 | |
Kumari et al. | Design, synthesis, molecular docking and dynamic studies of novel thienopyrimidine analogs linked to 1, 2, 3-triazole-bearing acetamide derivatives as anti-oxidant agents | |
CN106046019B (zh) | 一种l-缬氨酸取代去甲斑蝥素衍生物及其制备方法与应用 | |
CN110790677B (zh) | 一种金刚烷甲酰胺类化合物及其制备方法和应用 | |
CN109232571B (zh) | 一种对甲巯基取代含哒嗪酮结构的螺[吲哚嗪-吡唑啉]衍生物及其制备方法与应用 | |
CN110128446B (zh) | 3,4,5-三甲氧基苯基取代含色酮结构的螺[吲唑-异噁唑]衍生物及制备方法与应用 | |
CN107674082B (zh) | 一种含哒嗪酮结构的d-苯丙氨酸取代去甲斑蝥素衍生物的制备方法及其应用 | |
CN108026078A (zh) | 1-(4-(2-((1-(3,4-二氟苯基)-1h-吡唑-3-基)甲氧基)乙基)哌嗪-1-基)乙酮盐 | |
CN103601695B (zh) | (s)-4-苄基-3-丙酰基-2-恶唑烷酮的制备方法 | |
DE202024100159U1 (de) | Ein System zur Synthese von Imidazo[1,2-a]pyridin-Derivaten als potenzielle zytotoxische und antioxidante Mittel | |
CN106083967A (zh) | 含阿拉伯糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN105669654A (zh) | 一种伏立康唑铜配合物的制备方法及其抑菌活性 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG AOXIANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHENGZHOU UNIVERSITY Effective date: 20130514 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 450052 ZHENGZHOU, HENAN PROVINCE TO: 317016 TAIZHOU, ZHEJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130514 Address after: 317016 Zhejiang chemical raw materials base in the East China Sea Park Road, No. fourth, No. 5 Patentee after: Zhejiang Ausun Pharmaceutical Co., Ltd. Address before: 450052 No. 75 University North Road, Zhengzhou, Henan Patentee before: Zhengzhou University |
|
C56 | Change in the name or address of the patentee |
Owner name: ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: ZHEJIANG AOXIANG PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 317016 Zhejiang chemical raw materials base in the East China Sea Park Road, No. fourth, No. 5 Patentee after: Zhejiang Ao Xiang medicine company limited-liability company Address before: 317016 Zhejiang chemical raw materials base in the East China Sea Park Road, No. fourth, No. 5 Patentee before: Zhejiang Ausun Pharmaceutical Co., Ltd. |